Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis

By sjmartinez • July 14, 2024

Girard N, Besada M, Rogula B, Lucherini S, Vo L, Chaudhary MA, Goring S, Lozano-Ortega G, Tran M, Varol N, Waser N, Lee JM, Spicer J. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers (Basel). 2024 Jul 8;16(13):2492. doi: 10.3390/cancers16132492. PMID: 39001554; PMCID: PMC11240383.

Tags: Network meta-analysis, Publications, Pulmonary, Critical Care & Sleep Medicine, resectable non-small-cell lung cancer, Systematic literature review

Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness

Lee CI, Lowry KP, Elmore JG. Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness. J Natl Cancer Inst. 2026 Jul 6:djag121.[...]

In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at ≤48 wk

Hoo GWS; ACP Journal Club Editorial Team at McMaster University. In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve[...]

Nuclear mechanotransduction: tools for mechanical perturbation and chromatin characterization

Soto J, Origer N, Wu Y, Cardenas Benitez B, Massad R, Rahgoshay D, Lee A, Downing T, Li S. Nuclear mechanotransduction: tools for mechanical perturbation[...]